Malo PENVEN

Dr. Malo PENVEN


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
SRSophie Reissier
Sophie Reissier
MPMalo PENVEN
Malo PENVEN
FGFrançois Guérin
François Guérin
Vincent CattoirVincent Cattoir
Vincent Cattoir
Anaerobic bacteria are normal inhabitants of the human commensal microbiota and play an important role in various human infections. Tedious and time-consuming, antibiotic susceptibility testing is not routinely performed in all clinical microbiology laboratories, despite the increase in antibiotic resistance among clinically relevant anaerobes since the 1990s. β-lactam and metronidazole are the key molecules in the management of anaerobic infections, to the detriment of clindamycin. β-lactam resistance is usually mediated by the production of β-lactamases. Metronidazole resistance remains uncommon, complex, and not fully elucidated, while metronidazole inactivation appears to be a key mechanism. The use of clindamycin, a broad-spectrum anti-anaerobic agent, is becoming problematic due to the increase in resistance rate in all anaerobic bacteria, mainly mediated by Erm-type rRNA methylases. Second-line anti-anaerobes are fluoroquinolones, tetracyclines, chloramphenicol, and linezolid. This review aims to describe the up-to-date evolution of antibiotic resistance, give an overview, and understand the main mechanisms of resistance in a wide range of anaerobes.

26 July 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
MBMarion Beviere
Marion Beviere
SRSophie Reissier
Sophie Reissier
MPMalo PENVEN
Malo PENVEN
LDLoren Dejoies
Loren Dejoies
FGFrançois Guérin
François Guérin
CPCaroline François Piau
Caroline François Piau
Next-generation sequencing (NGS) has modernized the field of tuberculosis (TB) research by enabling high-throughput sequencing of the entire genome of Mycobacterium tuberculosis (MTB), which is the causative agent of TB. NGS has provided insights into the genetic diversity of MTB, which are crucial for understanding the evolution and transmission of the disease, and it has facilitated the identification of drug-resistant strains, enabling rapid and accurate tailoring of treatment. However, the high cost and the technical complexities of NGS currently limit its widespread use in clinical settings. International recommendations are thus necessary to facilitate the interpretation of polymorphisms, and an experimental approach is still necessary to correlate them to phenotypic data. This review aims to present a comparative, step-by-step, and up-to-date review of the techniques available for the implementation of this approach in routine laboratory workflow. Ongoing research on NGS for TB holds promise for improving our understanding of the disease and for developing more efficacious treatments.

22 October 2025 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
MPMalo PENVEN
Malo PENVEN
HLHugo Leroyer-Gravet
Hugo Leroyer-Gravet
ACAminata Cisse
Aminata Cisse
MLMaxime Lecourt
Maxime Lecourt
TMTony Marchand
Tony Marchand
VCVincent Cattoir
Vincent Cattoir